Join us for this insightful interview with Dan Riley, CEO of Genefic, as he shares important news, updates, and highlights of Genefic’s healthcare expansion as the subsidiary continues its impressive revenue growth.
Riley’s interview with SmallCapVoice details the company’s ongoing success in the specialty pharmacy space, the diagnostics sector, and infusion pharmaceuticals—a direct result of its long-term strategy and vision that was officially launched in late 2023. Genefic now has two licensed diagnostic laboratories, a 50-state licensed specialty pharmacy, and a recently-acquired infusion pharmacy in New Orleans, and has even bigger plans ahead.
Viewers will get an exclusive look into the future of Genefic, including exciting plans to add a compounding pharmacy. With record-breaking previous fiscal quarters, Dan provides a deep dive into what’s driving Genefic’s success and what’s next on the horizon. Don’t miss out on this exclusive interview!